Fresenius SE Other Share Holders Equity 2016-2024 | FSNUY

Fresenius SE other share holders equity from 2016 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Fresenius SE other share holders equity for the quarter ending June 30, 2024 was $14.957B, a 9.1% decline year-over-year.
  • Fresenius SE other share holders equity for 2023 was $15.252B, a 4.27% decline from 2022.
  • Fresenius SE other share holders equity for 2022 was $15.933B, a 9.38% decline from 2021.
  • Fresenius SE other share holders equity for 2021 was $17.581B, a 13.71% increase from 2020.
Fresenius SE Annual Other Share Holders Equity
(Millions of US $)
2023 $15,252
2022 $15,933
2021 $17,581
2020 $15,461
2019 $13,913
2018 $13,289
2017 $10,914
2016 $9,193
2015 $7,788
Fresenius SE Quarterly Other Share Holders Equity
(Millions of US $)
2024-06-30 $14,957
2024-03-31 $15,617
2023-12-31 $15,252
2023-09-30 $16,017
2023-06-30 $16,454
2023-03-31 $16,640
2022-12-31 $15,933
2022-09-30 $14,944
2022-06-30 $16,138
2022-03-31 $17,155
2021-12-31 $17,581
2021-09-30 $16,924
2021-06-30 $16,794
2021-03-31 $16,841
2020-12-31 $15,461
2020-09-30 $15,335
2020-06-30 $14,501
2020-03-31 $14,094
2019-12-31 $13,913
2019-09-30 $13,324
2019-06-30 $13,023
2019-03-31 $13,246
2018-12-31 $13,289
2018-09-30 $12,486
2018-06-30 $12,316
2018-03-31 $12,406
2017-12-31 $10,914
2017-09-30 $10,755
2017-06-30 $9,632
2017-03-31 $9,183
2016-12-31 $9,193
2016-09-30 $8,707
2016-06-30 $8,437
2016-03-31 $8,137
2015-12-31 $15,948
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $20.039B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.877B 18.12
DaVita (DVA) United States $12.667B 16.38
Encompass Health (EHC) United States $10.405B 24.53
Chemed (CHE) United States $8.459B 26.00
Elanco Animal Health (ELAN) United States $7.054B 16.79
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
U.S Physical Therapy (USPH) United States $1.428B 37.54
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.042B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00